u w [ òâ¸p
TRANSCRIPT
胃部分切除術後•1日目から動ける•2日目から水•3日目から食事•7日目点滴終了、退院許可
2006年から開始09.12月までに140名に施行
術後10日前後で退院、合併症は5例
体への負担や合併症も少なく開腹手術よりいいくらいです
キズの小さいやさしい手術
日本の現状
90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 070
2,000
4,000
6,000
8,000
10,000
食道癌 胃癌 大腸癌
内視鏡外科学会 技術認定制度
目的:安全な手術を患者様に提供すること
認定医:内視鏡手術を完遂、指導できること
2004年から制度を開始試験の合格率は40%前後
要するに技術テストです認定医もいますし、他の外科医も試験合格を目指し頑張っております
学会が中心になり安全な手術のための努力
腹腔鏡でも十分治る!
再発率
n engl j med
350;20
www.nejm.org may
13
,
2004
The
new england journal
of
medicine
2056
ed colectomy is not associated with a significantincrease in overall complications.
In addition, other operative factors, includingthe extent of resection — specifically, the number oflymph nodes sampled, the length of bowel andmesentery resected, and the bowel margins — didnot differ significantly between patients who under-went laparoscopically assisted surgery and thosewho underwent open colectomy. It will never be pos-sible to determine whether laparoscopically assistedand open surgery provide the same degree of accu-racy in terms of intraabdominal staging. Theoreti-cally, laparoscopy may be inferior owing to the lossof tactile information provided by traditional sur-gical techniques. In practice, laparoscopy coupled
with solid-organ imaging offers visual capabilitiesthat seem to provide adequate staging information.The finding that the percentage of patients foundto have metastatic disease at surgery did not differsignificantly between groups provides indirect evi-dence of the adequacy of laparoscopic staging. Fur-thermore, there was no trend toward a higher rate ofrecurrence overall or among patients with stage IIIdisease in the group treated laparoscopically, sug-gesting that the presence of undetected abdominalmetastases is not an important limitation of thelaparoscopic approach.
Our finding that laparoscopically assisted colec-tomy, as evaluated in our controlled setting, is safefor patients with colon cancer must be applied cau-
Figure 2. Cumulative Incidence of Recurrence among Patients with Colon Cancer of Any Stage (Panel A), Stage I (Panel B), Stage II (Panel C), or Stage III (Panel D).
The tumor–node–metastasis stage was used. Patients with benign pathological conditions were excluded from this analysis.
1.0
Cum
ulat
ive
Inci
denc
eof
Rec
urre
nce
0.80.9
0.70.6
0.40.3
0.1
0.5
0.2
1.0
0.80.9
0.70.6
0.40.3
0.1
0.5
0.2
0.0
1.0
Cum
ulat
ive
Inci
denc
eof
Rec
urre
nce
0.80.9
0.70.6
0.40.3
0.1
0.5
0.2
0.0
1.0
Cum
ulat
ive
Inci
denc
eof
Rec
urre
nce
0.80.9
0.70.6
0.40.3
0.1
0.5
0.2
0.0
0 1 2 3 4 5
Open colectomy
Laparoscopicallyassisted colectomy
Years
No. at RiskOpen colectomyLaparoscopically
assistedcolectomy
109 118
177 185
240 242
289 311
345 368
395 415
Cum
ulat
ive
Inci
denc
eof
Rec
urre
nce
0.00 1 2 3 4 5
Open colectomy
Laparoscopicallyassisted colectomy
Years
No. at RiskOpen colectomyLaparoscopically
assistedcolectomy
39 56
66 81
85 110
97 133
104 146
112 153
0 1 2 3 4 5
Open colectomy
Laparoscopicallyassisted colectomy
Years
No. at RiskOpen colectomyLaparoscopically
assistedcolectomy
46 37
69 59
93 76
112 103
135 120
146 136
0 1 2 3 4 5
Open colectomy
Laparoscopicallyassisted colectomy
Years
No. at RiskOpen colectomyLaparoscopically
assistedcolectomy
24 25
42 45
62 56
80 73
107 99
121 112
A All Stages B Stage I
C Stage II D Stage III
P=0.32 P=0.65
P=0.50 P=0.49
Copyright © 2004 Massachusetts Medical Society. All rights reserved. Downloaded from www.nejm.org at KENRITSU-SEIJINBYO-CENTER on April 26, 2007 .